4//SEC Filing
Sarepta Therapeutics, Inc. 4
Accession 0001181431-13-033359
$SRPTCIK 0000873303operating
Filed
Jun 5, 8:00 PM ET
Accepted
Jun 6, 9:56 PM ET
Size
7.5 KB
Accession
0001181431-13-033359
Insider Transaction Report
Form 4
Goolsbee William Alden
Director
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2013-06-04+20,000→ 20,000 totalExercise: $34.92From: 2014-06-04Exp: 2023-06-04→ Common Stock (20,000 underlying) - Award
Common Stock
2013-06-04+1,000→ 5,166 total
Footnotes (3)
- [F1]On June 6, 2013, Sarepta Therapeutics, Inc., a Delaware corporation, became the successor of Sarepta Therapeutics, Inc., an Oregon corporation, pursuant to a merger. The merger had the effect of changing the state of incorporation of Sarepta Therapeutics, Inc. from Oregon to Delaware, but did not alter the proportionate interests of security holders.
- [F2]Grant of restricted stock, which shall vest in full on the anniversary date of the grant.
- [F3]This option will vest at a rate of 25% annually over four years beginning on the first anniversary of the date of grant.
Documents
Issuer
Sarepta Therapeutics, Inc.
CIK 0000873303
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000873303
Filing Metadata
- Form type
- 4
- Filed
- Jun 5, 8:00 PM ET
- Accepted
- Jun 6, 9:56 PM ET
- Size
- 7.5 KB